Definitive Healthcare Corp. (DH) shares plummeted 13.62% in the after-hours trading session on Thursday, following the company's financial results for the fourth quarter and full fiscal year 2024. The healthcare commercial intelligence provider reported a significant net loss due to substantial goodwill impairment charges, along with a weak outlook for the first quarter of 2025.

In the fourth quarter of 2024, Definitive Healthcare recorded a net loss of $84.7 million, or 136% of revenue, largely driven by $97.1 million in goodwill impairment charges. The company's adjusted EBITDA declined to $17.5 million, or 28% of revenue, compared to $19.8 million, or 30% of revenue, in the same period last year.

For the full year 2024, Definitive Healthcare reported a net loss of $591.4 million, or 235% of revenue, including goodwill impairment charges of $688.9 million. While the company's revenue grew marginally to $252.2 million, its adjusted EBITDA margin improved slightly to 31% from 30% in 2023.